Ventria Bioscience and Medicines
In 2002, Scott Deeter was hired as CEO of Ventria to assist Dr. Raymond Rodriguez with a few Projects. Ventria was unable to obtain the necessary permits to begin their commercial production for the production of pharmaceutical proteins found in the seeds of rice.
This medicine was designed to lessen the severity of diarrhea in children. Many different rganizations were against them such as environmentalists, food safety activists, consumer advocates, rice farmers and the California Secretary of Agriculture making it difficult for Ventria to plant their rice seeds. Describe the relevant stakeholders and for each, state its interests and sources of power.
- Scott Deeter, President and CEO of Ventria Bioscience;
- Dr. Raymond Rodriguez, founder and biologist on the faculty of the University of California-Davis;
- Dr. William Rutter, investor and founder and board chairman of the Emeryville, biotechnology firm Chiron;
Board of directors, eaders and seasoned entrepreneurs-they provided more than 85 percent of the company’s financing.
Describe the options that might emerge from a dialogue between Ventria and its relevant stakeholders.
Describe how Ventria might go about influencing relevant regulators if it chooses to employ a political action strategy. Describe what other options Ventria has if it chooses not to engage in dialogue or political action. Recommend what Ventria should do now and explain why.
